Document Security Systems, a provider of anti-counterfeit, authentication and diversion protection technologies, agreed to acquire Impact Biomedical, a company engaged in the development and marketing of biohealth security technologies, for $50m. "DSS is continuing to pursue its strategy of diversification and this acquisition represents the dedicated efforts of our team to identify assets that we expect will be accretive to our business while approaching the structural acquisition thereto with creativity and an eye towards creating lasting shareholder value. We are pleased to advance our business expansion efforts with IMPACT to continue leading the way in industry security technologies," Jason Grady, DSS COO.